ArticleNature communications2026
Dimensional control of low-dimensional perovskite hybrids for photovoltaics.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Balancing Shading and Resistive Losses: 33% Efficient Perovskite/Silicon Tandem Solar Cells via Front-Electrode Engineering.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Suppressing Interfacial-Accelerated Degradation in Perovskite Solar Cells via Supramolecular Co-Assembly.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Low-dimensional perovskite engineering offers a promising route to improve both power conversion efficiency and stability in perovskite photovoltaics, yet the mechanistic relationship between organic ligand design and structural control remains elusive. Here, we report a molecular design strategy for bis-imidazolium ligands that enables precise dimensional tuning of perovskite architectures, from zero-dimensional through parallel one-dimensional to bridged zero-dimensional configurations. Through systematic variation of terminal groups and inter-imidazole spacing, we achieve controlled growth of high-quality hybrid dimensional perovskite films with optimized crystallization kinetics and charge transport properties. This enables photovoltaic devices with a certified power conversion efficiency of 27.02% (laboratory 27.21%). Scaling this dimensional strategy enables the fabrication of 30×30 cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.